Charles River To Acquire CDMO Cognate BioServices for $875 M
By
Charles River Laboratories, a Wilmington, Massachusetts-headquartered contract research organization, has agreed to acquire Cognate BioServices, a CDMO specializing in cell and cell-mediated gene-therapy products, for approximately $875 million. Cognate provides…